Cite
HARVARD Citation
Gruosso, T. et al. (n.d.). 504PAVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors. Annals of oncology. p. . [Online].